Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
Zottel, Alja, JovÄevska, Ivana, Å amec, Neja, Mlakar, Jernej, Å ribar, Jernej, Križaj, Igor, Skoblar Vidmar, Marija, Komel, RadovanVolume:
12
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835920915302
Date:
January, 2020
File:
PDF, 4.41 MB
2020